Table 3 Cardiorespiratory variables in the 15 patients that received ECCO2R

HR (beats per minutes)

87 ± 15

95 ± 21

94 ± 20

98 ± 19

104 ± 19

105 ± 19

104 ± 17

MAP (mmHg)

77 ± 10

76 ± 11

71 ± 11

72 ± 11

73 ± 11

73 ± 12

76 ± 9

mPAP (mmHg)

31 ± 10

34 ± 8

31 ± 10

28 ± 11

29 ± 8

29 ± 10

25 ± 6

PVC (mmHg)

12 ± 5.3

13 ± 4

13 ± 5.5

12 ± 5.4

13 ± 5.4

14 ± 5.9

14 ± 5

CI (l/min/m²)

2.7 ± 0.8

2.9 ± 1

3.0 ± 0.9

3.1 ± 1

3.6 ± 1

3.1 ± 1.2

3.0 ± 0.7

SvO2 (%)

82 ± 8

79 ± 11

82 ± 9

83 ± 6

82 ± 7

79 ± 10

81 ± 7

pH

7.31 ± 0.1

7.20 ± 0.1

7.28 ± 0.1*

7.30 ± 0.1

7.26 ± 0.1

7.33 ± 0.1

7.36 ± 0.1

PaO₂/FiO₂

359 ± 131

238 ± 179

309 ± 169

340 ± 171

155 ± 90

210 ± 167

264 ± 164

PaCO₂ (mmHg)

68 ± 22

86 ± 24

63 ± 20*

58 ± 14

63 ± 13

56 ± 16

49 ± 12

SpO₂ (%)

99 ± 2

97 ± 3

99 ± 2

99 ± 4

93 ± 11

97 ± 7

99 ± 1

BE (mmol/l)

6.1 ± 9

2.8 ± 3.2

1.9 ± 9

1.0 ± 6

0.7 ± 7

2.1 ± 6

1.2 ± 5

HCO3^- (mmol/l)

31 ± 8

28.7 ± 3.7

27 ± 8

26 ± 4

26 ± 6

27 ± 5

26 ± 4

Lac (mmol/l)

0.8 ± 0.5

0.6 ± 0.3

1.2 ± 0.7

1.7 ± 1.2

5.1 ± 13

2.5 ± 2.1

4.7 ± 3.9